InsiderClue
Insiders · Profile

Katkin Keith

Director at Emergent BioSolutions · Director at Syndax Pharmaceuticals. Filing since 30 Sep 2022. CIK 0001314596

EBS Emergent BioSolutions Inc. Director · 2 trades SNDX Syndax Pharmaceuticals Inc Director · 5 trades
Company
Date
Role
Action
Shares
Amount
Of holding
EBS Emergent BioSolutions Inc.
30 Apr 2026
Director
Sold on a plan
15,481
$128.18K
13.9%
EBS Emergent BioSolutions Inc.
23 May 2025
Director
Sold on a plan
7,844
$49.42K
8.3%
SNDX Syndax Pharmaceuticals Inc
19 May 2025
Director
Bought
10,000
$91.12K
11.1%
SNDX Syndax Pharmaceuticals Inc
6 Oct 2022
Director
Sold, plan not stated
29,899
$774.41K
48.3%
SNDX Syndax Pharmaceuticals Inc
4 Oct 2022
Director
Sold, plan not stated
360
$9.00K
1.1%
SNDX Syndax Pharmaceuticals Inc
3 Oct 2022
Director
Sold, plan not stated
180
$4.50K
0.6%
SNDX Syndax Pharmaceuticals Inc
30 Sep 2022
Director
Sold, plan not stated
3,561
$89.28K
10.0%
7 decisions on file.